Intracerebroventricular infusion of leptin decreases serotonin transporter binding sites in the frontal cortex of the rat

Neuroscience Letters

Volumn 283, Issue 2, 2000, Pages 89-92

  Charnay, Yves ^a   Cusin, Isabelle ^b   Vallet, Philippe G ^a   Muzzin, Patrick ^c   Rohner Jeanrenaud, Françoise ^b   Bouras, Constantin ^a  

^a Division of Neuropsychiatry   (Switzerland)

^b HUG Ch Petit Bel Air 2 C   (Switzerland)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

5 HT; Antidepressant binding sites; Lean Zucker; Leptin; Rat brain

Indexed keywords

LEPTIN; PAROXETINE; SEROTONIN TRANSPORTER; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DEPRESSION; DORSAL RAPHE NUCLEUS; DRUG INFUSION; DRUG RECEPTOR BINDING; FOOD INTAKE; FRONTAL CORTEX; MALE; MEDIAN RAPHE NUCLEUS; NONHUMAN; PATHOPHYSIOLOGY; PERIKARYON; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; SEROTONINERGIC SYSTEM;

ANIMALS; BINDING SITES; CARRIER PROTEINS; CEREBRAL VENTRICLES; FRONTAL LOBE; INFUSIONS, PARENTERAL; KINETICS; LEPTIN; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; PAROXETINE; RATS; RATS, ZUCKER; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; THINNESS;

EID: 0034615847     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)00951-4     Document Type: Article

References (17)

1. Calapai G., Corica F., Corsonello A., Sautebin L., Di Rosa M., Campo G.M., Buemi M., Mauro V.N., Caputi A.P. Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis. J. Clin. Invest. 104:1999;975-982.
2. Charnay Y., Leger L., Vallet P.G., Greggio B., Hof P.R., Jouvet M., Bouras C. Mapping of serotonin transporter messenger RNA-containing nerve cell populations in the cat brainstem. J. Chem. Neuroanat. 10:1996;93-100.
3. 3H]paroxetine binding sites: brain regional differences between two psychogenetically selected lines of rats. Neurosci. Res. Comm. 16:1995;29-35.
4. 3H]5-HT uptake: effect of administration of various antidepressant treatments. Neuropharmacology. 32:1993;737-743.
5. Cusin I., Zakrzewska K.E., Boss O., Muzzin P., Giacobino J.P., Ricquier D., Jeanrenaud B., Rohner-Jeanrenaud F. Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins. Diabetes. 47:1998;1014-1019.
6. 3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region. Synapse. 9:1991;14-26.
7. Dryden S., Brown M., King P., Williams G. Decreased plasma leptin levels in lean and obese Zucker rats after treatment with the serotonin reuptake inhibitor fluoxetine. Horm. Metab. Res. 31:1999;363-366.
8. 3H]paroxetine binding to rat cortical membranes. Eur. J. Pharmacol. 118:1985;107-114.
9. Huether G., Zhou D., Schmidt S., Wiltfang J., Ruther E. Long-term food restriction down-regulates the density of serotonin transporters in the rat frontal cortex. Biol. Psychiatry. 41:1997;1174-1180.
10. Konopleva M., Mikhail A., Estrov Z., Zhao S., Harris D., Sanchez-Williams G., Kornblau S.M., Dong J., Kliche K.O., Jiang S., Snodgrass H.R., Estey E.H., Andreeff M. Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities. Blood. 93:1999;1668-1676.
11. Leibowitz S.F., Alexander J.T. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol. Psychiatry. 44:1998;851-864.
12. Lesch K.P. Molecular biology, pharmacological properties, and genetics of the serotonin transporter: psychobiological and clinical implications. Born G.V.R. Handbook of Experimental Pharmacology. Vol. 129:1997;671-705 Springer, Berlin.
13. Lesch K.P., Aulakh C.S., Wolozin B.L., Tolliver T.J., Hill J.L., Murphy D.L. Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Mol. Brain Res. 17:1993;31-35.
14. Maffei M., Halaas J., Ravussin E., Pratley R.E., Lee G.H., Zhang Y., Fei H., Kim S., Lallone R., Ranganathan S., Kern P.A., Friedman J.M. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1:1995;1155-1161.
15. Shioda S., Funahashi H., Nakajo S., Yada T., Maruta O., Nakai Y. Immunohistochemical localization of leptin receptor in the rat brain. Neurosci. Lett. 243:1998;41-44.
16. Williams L.M., Adam C.L., Mercer J.G., Moar K.M., Slater D., Hunter L., Findlay P.A., Hoggard N. Leptin receptor and neuropeptide Y gene expression in the sheep brain. J. Neuroendocrinol. 11:1999;165-169.
17. Zarjevski N., Cusin I., Vettor R., Rohner-Jeanrenaud F., Jeanrenaud B. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology. 133:1993;1753-1758.